V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20194503 | 20152111 | 1.63 | 88.4 | null | 2022-05-11 | 2022-05-18 | CISPLATIN + GEMCITABINE | null | null | CISPLATIN + GEMCITABINE | 101612119 |
| 20194504 | 20152112 | 1.55 | 65.85 | null | 2015-10-01 | 2020-04-22 | CISPLATIN + GEMCITABINE | N | null | CISPLATIN + GEMCITABINE | 101378505 |
| 20194510 | 20152113 | 1.65 | 69.8 | Palliative (P) | 2019-08-03 | 2019-08-13 | CISPLATIN + GEMCITABINE | N | null | CISPLATIN + GEMCITABINE | 101239912 |
| 20194513 | 20152114 | 1.63 | 55.2 | Palliative (P) | 2018-06-25 | 2018-08-06 | Cisplatin+Gemcitabine (gallbladder) | 02 | N | CISPLATIN + GEMCITABINE | 101193527 |
| 20194515 | 20152115 | 1.57 | 57.8 | Palliative (P) | 2016-07-17 | 2016-07-19 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 101260317 |
| 20194520 | 20152116 | 1.83 | 104.3 | null | 2017-04-18 | 2017-04-24 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | CISPLATIN + GEMCITABINE | 101061028 |
| 20194527 | 20152117 | 1.5 | 93 | null | 2018-06-28 | 2018-07-03 | Capecitabine (21 day) + Irinotecan | 02 | null | CAPECITABINE + IRINOTECAN | 100989980 |
| 20194528 | 20152118 | 1.69 | 58.8 | Palliative (P) | 2016-12-03 | 2016-12-15 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 100825719 |
| 20194532 | 20152119 | 1.57 | 74.4 | null | 2016-12-09 | 2017-01-23 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | CISPLATIN + GEMCITABINE | 100590858 |
| 20194536 | 20152120 | 1.82 | 62.8 | Palliative (P) | 2019-10-12 | 2019-10-22 | CAPECITABINE + IRINOTECAN | 02 | N | CAPECITABINE + IRINOTECAN | 101469529 |
| 20194538 | 20152121 | 1.52 | 98 | null | 2016-06-03 | 2016-06-04 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | CISPLATIN + GEMCITABINE | 100679867 |
| 20194542 | 20152122 | 1.7 | 70.8 | Palliative (P) | 2021-07-02 | 2021-07-06 | CAPECITABINE + IRINOTECAN | 02 | null | CAPECITABINE + IRINOTECAN | 100478716 |
| 20194557 | 20152123 | null | 72.1 | Adjuvant (A) | 2018-09-26 | 2018-11-01 | CAPECITABINE + IRINOTECAN | 02 | N | CAPECITABINE + IRINOTECAN | 101706941 |
| 20194568 | 20152124 | 1.55 | 84.6 | Palliative (P) | 2017-02-01 | 2017-06-03 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 101442055 |
| 20194579 | 20152125 | 1.63 | 67.75 | Palliative (P) | 2020-12-14 | 2020-12-28 | Cisplatin+Gemcitabine (gallbladder) | 02 | N | CISPLATIN + GEMCITABINE | 100111215 |
| 20194581 | 20152126 | 1.78 | 101.8 | Palliative (P) | 2016-03-20 | 2016-03-22 | CISPLATIN + GEMCITABINE | 2 | N | CISPLATIN + GEMCITABINE | 100719544 |
| 20194589 | 20152127 | 1.57 | 71.8 | Palliative (P) | 2019-01-09 | 2019-01-24 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 101055181 |
| 20194590 | 20152128 | 1.83 | 60.8 | Palliative (P) | null | 2021-12-21 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100183363 |
| 20194594 | 20152129 | 1.85 | 71.7 | Adjuvant (A) | null | 2021-03-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101660888 |
| 20194598 | 20152130 | 1.76 | 82.2 | null | 2016-09-07 | 2016-09-18 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100860541 |
| 20194609 | 20152131 | 1.59 | 70 | Neo-adjuvant (N) | null | 2018-03-08 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101266657 |
| 20194618 | 20152132 | 1.76 | 60.3 | Palliative (P) | 2020-02-14 | 2020-02-28 | Gemcitabine + Capecitabine | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101284341 |
| 20194622 | 20152133 | 1.68 | 112 | null | 2016-04-14 | 2016-04-22 | Gemcitabine + Capecitabine | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101051646 |
| 20194624 | 20152134 | 1.69 | 101.3 | Palliative (P) | 2016-11-19 | 2016-11-27 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100714858 |
| 20194629 | 20152135 | 1.61 | 68 | Palliative (P) | 2021-08-14 | 2021-08-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101799621 |
| 20194630 | 20152136 | 1.67 | 106.5 | Palliative (P) | 2019-09-08 | 2019-09-14 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100329208 |
| 20194634 | 20152137 | 1.7 | 84 | Palliative (P) | 2018-07-05 | 2018-08-07 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101636356 |
| 20194636 | 20152138 | 1.65 | 62.9 | Adjuvant (A) | 2017-04-18 | 2017-07-15 | Docetaxel | null | N | DOCETAXEL | 101448548 |
| 20194637 | 20152139 | 1.67 | 103.1 | Palliative (P) | 2019-11-26 | 2019-11-28 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100253224 |
| 20194642 | 20152140 | 1.73 | 106 | null | 2018-09-08 | 2018-09-25 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101836040 |
| 20194645 | 20152141 | 1.76 | 62.9 | Palliative (P) | 2018-04-14 | 2018-05-21 | Docetaxel 75mg/m2 (21 day) | 99 | N | DOCETAXEL | 101603838 |
| 20194646 | 20152142 | null | 64.5 | null | 2018-02-03 | 2018-02-09 | Docetaxel | 02 | null | DOCETAXEL | 101210966 |
| 20194653 | 20152143 | 1.72 | 71.4 | Palliative (P) | 2019-05-06 | 2019-05-29 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100955567 |
| 20194666 | 20152144 | 1.66 | 62.8 | Palliative (P) | 2016-10-03 | 2016-10-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101282101 |
| 20194669 | 20152145 | 2 | 62 | null | null | 2018-10-04 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100734143 |
| 20194670 | 20152146 | 1.7 | 54.4 | Palliative (P) | 2017-10-05 | 2019-01-15 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101286676 |
| 20194685 | 20152147 | 1.68 | 61.4 | Palliative (P) | 2019-11-02 | 2019-11-02 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100512321 |
| 20194696 | 20152148 | 1.6 | 91.9 | null | 2016-08-22 | 2016-09-16 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101545694 |
| 20194697 | 20152149 | 1.8 | 76 | Palliative (P) | 2018-06-30 | 2018-07-21 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 100479928 |
| 20194709 | 20152150 | 1.53 | 68 | Palliative (P) | 2016-12-17 | 2017-06-04 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 101408957 |
| 20194713 | 20152151 | 1.82 | 61 | null | 2016-08-22 | 2016-11-25 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100823389 |
| 20194715 | 20152152 | 1.7 | 86.8 | Palliative (P) | 2018-08-17 | 2018-08-19 | Cetuximab + FOLFIRI cycle1 | 02 | N | DOCETAXEL | 100362188 |
| 20194720 | 20152153 | 1.7 | 82.9 | null | 2021-04-21 | 2021-04-21 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100534322 |
| 20194728 | 20152154 | 1.83 | 66.3 | null | null | 2019-05-20 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101833920 |
| 20194745 | 20152155 | 1.87 | 72 | Neo-adjuvant (N) | 2016-04-28 | 2016-05-04 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100238434 |
| 20194747 | 20152156 | 1.66 | null | Palliative (P) | 2019-08-11 | 2019-08-22 | Docetaxel | 02 | N | DOCETAXEL | 101647243 |
| 20194752 | 20152157 | 1.76 | 62 | null | 2019-08-11 | 2019-12-05 | Cetuximab + FOLFIRI cycle1 | 02 | null | CAPECITABINE + GEMCITABINE | 100771060 |
| 20194766 | 20152158 | 1.83 | 67.3 | Neo-adjuvant (N) | 2018-05-26 | 2018-06-13 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100632941 |
| 20194771 | 20152159 | 1.61 | 51 | null | 2019-04-05 | 2019-05-03 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101532009 |
| 20194774 | 20152160 | 1.63 | 55.7 | Palliative (P) | 2016-07-11 | 2016-10-22 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100383623 |